Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience
- 15 November 2004
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 35 (3), 253-260
- https://doi.org/10.1038/sj.bmt.1704760
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2004
- Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsBlood, 2004
- Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumorsBlood, 2003
- Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinomaBone Marrow Transplantation, 2003
- Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimenCancer, 2002
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- In situ demonstration of renal-cell-carcinoma-specific T-cell clonesInternational Journal of Cancer, 1996
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.Journal of Clinical Oncology, 1995
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981